UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medipost, LG Chem to develop stem cell therapy
Medipost said Monday that it has signed a cooperation agreement with LG Che...
by Lee Han-soo
|
2019-01-08 17:55
라인
Samsung Bioepis to expand business in China
Samsung Bioepis has signed a licensing agreement with 3SBio, a Chinese biot...
by Lee Han-soo
|
2019-01-07 12:30
라인
Celltrion’s Truxima claims 35% of European rituximab market
Celltrion Healthcare said Thursday that Truxima (Ingredient: rituximab-abbs...
by Lee Han-soo
|
2019-01-04 15:54
라인
Alteogen wins patent on optimizing incubation conditions for Eylea biosimilar
Alteogen said Wednesday that it has registered a patent on quality improvem...
by Lee Han-soo
|
2019-01-03 16:01
라인
Newly listed pharmaceuticals suffer market cap declines
Market capitalizations of pharmaceutical and biotech companies that went pu...
by Nam Doo-hyun
|
2018-12-21 15:13
라인
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun
|
2018-12-17 12:48
라인
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun
|
2018-12-13 15:33
라인
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun
|
2018-12-12 16:27
라인
Samsung BioLogics, Celltrion shares soar despite uncertainty
The share prices of Samsung BioLogics and Celltrion rose Wednesday even tho...
by Lee Han-soo
|
2018-12-12 16:27
라인
Machine learning finds biomarker for rare Castleman Disease
Medidata, a cloud-based solution provider for clinical research, said it ha...
by Lee Hye-seon
|
2018-12-11 17:11
라인
Viromed finds prostate hyperplasia treatment effect in natural substance
A team of researchers at the Viromed’s natural product research group said ...
by Lee Han-soo
|
2018-12-11 14:55
라인
Samsung BioLogics resumes trading despite controversies
The Korea Exchange (KRX) has decided to allow continued trading of Samsung ...
by Lee Han-soo
|
2018-12-11 10:50
라인
Celltrion unveils clinical trial results for rituximab biosimilar in US
Celltrion Healthcare has presented a clinical trial, which showed the effic...
by Lee Han-soo
|
2018-12-06 11:11
라인
Samsung BioLogics, Saint-Gobain sign supply agreement
Samsung BioLogics said Wednesday that it has signed a single-use raw materi...
by Lee Han-soo
|
2018-12-05 14:01
라인
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar
Chong Kun Dang Pharmaceutical said Sunday that it has become the first comp...
by Lee Han-soo
|
2018-12-04 11:18
라인
‘Rules to be tougher on patent transfer due to ToolGen case’
As the regulation on the patent transfer to a company from universities and...
by Nam Doo-hyun
|
2018-11-29 11:48
라인
Celltrion wins FDA nod for rituximab biosimilar
Celltrion said Thursday that the U.S. Food and Drug Administration has appr...
by Lee Han-soo
|
2018-11-29 10:50
라인
Samsung BioLogics files administrative suit to refute accounting fraud ruling
Samsung BioLogics said it filed an administrative suit on Nov. 14 to nullif...
by Nam Doo-hyun
|
2018-11-28 15:30
라인
Pharmaceuticals, biotechs rise with KOSPI rebound
Shares of pharmaceutical and biotech companies moved up briskly on Monday, ...
by Nam Doo-hyun
|
2018-11-27 11:53
라인
Celltrion’s Remsima tops global sale of ₩1 trillion
Celltrion Healthcare said Thursday that Remsima, a biosimilar of Remicade t...
by Lee Han-soo
|
2018-11-23 14:54
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top